Osteoporotic Vertebral Compression Fractures: Can Kyphoplasty Improve Lung Function? A Prospective Evaluation

NCT ID: NCT01609712

Last Updated: 2012-06-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients with vertebral fractures often have problems to straighten and as a consequence of impaired lung ventilation that leads to a impaired lung function. Furthermore, it comes to the sintering of the vertebra and a so-called hunchback. This also contributes to the poorer expansion of the lung. Pain is also caused by respiratory excursions of the chest which hinder the patients to use their entire lung volume.

Kyphoplasty is designed to counter all these consequences of vertebral fractures by bringing stability to the fracture.

In order to prove the thesis the results of lung function test (FEV1, PEF) are assessed.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoporotic Vertebral Compression Fractures Lung Function

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patient with vertebral compression fracture

RF kyphoplasty is standard of care in our hospital for patients with osteoporortic compression fractures. We are intersetd, if it also can improve the lung function.

Radiofrequency Kyphoplasty

Intervention Type PROCEDURE

Radiofrequency kyphoplasty is a new form of surgical treatment. It injects an ultrahigh viscosity cement into the fractured vertebral body, using radiofrequency to achieve the proper consistency of the cement. This ultrahigh viscosity cement is designed to first restore proper height and alignment to the fractured vertebra and then to stabilize the fracture, thereby preventing further intravertebral motion and reducing pain.

The RF-Kyphoplasty is standard of care in our hospital. It is FDA and CE approved.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Radiofrequency Kyphoplasty

Radiofrequency kyphoplasty is a new form of surgical treatment. It injects an ultrahigh viscosity cement into the fractured vertebral body, using radiofrequency to achieve the proper consistency of the cement. This ultrahigh viscosity cement is designed to first restore proper height and alignment to the fractured vertebra and then to stabilize the fracture, thereby preventing further intravertebral motion and reducing pain.

The RF-Kyphoplasty is standard of care in our hospital. It is FDA and CE approved.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

RF-Kyphoplasty

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* over 50 years
* VAS over 49, ODI over 29
* radiographic evidence of A 1.1, 1.2, 1.3 fractures
* patients mentally capable to sign informed consent

Exclusion Criteria

* high-energy trauma
* known tumor involvement
* osteonecrotic fractures
* burst fractures or pedicle fractures
* previous surgical treatment for a vertebral body compression fracture
* patient has paget's disease
* BMI \> 35
* uncontrolled diabetes HbAc1c \> 7%
* severe cardiopulmonary disease
* Myelopathy
* long-time steroid therapy
Minimum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Bonn

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Robert Pflugmacher

PD Dr. med.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Robert Pflugmacher, M.D.

Role: PRINCIPAL_INVESTIGATOR

Orthopädie und Unfallchirurgie, Universitätsklinkum Bonn

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Orthopädie und Unfallchirurgie Universitätsklinikum Bonn

Bonn, North Rhine-Westphalia, Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Robert Pflugmacher, M.D.

Role: CONTACT

+4915158233263

Rahel Bornemann

Role: CONTACT

+49-160-2535164

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Robert Pflugmacher, M.D.

Role: primary

+49-151-58233263

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

B-O-P-LF-02

Identifier Type: OTHER

Identifier Source: secondary_id

B-O-P-LF-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.